LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 38

Search options

  1. Article ; Online: Recapitulating memory B cell responses in a Lymphoid Organ-Chip to evaluate mRNA vaccine boosting strategies

    Jeger-Madiot, Raphaël / Planas, Delphine / Staropoli, Isabelle / Kervevan, Jérôme / Mary, Héloïse / Collina, Camilla / Fonseca, Barbara F. / Debarnot, Hippolyte / Robinot, Rémy / Gellenoncourt, Stacy / Schwartz, Olivier / Ewart, Lorna / Bscheider, Michael / Gobaa, Samy / Chakrabarti, Lisa A.

    bioRxiv

    Abstract: Predicting the immunogenicity of candidate vaccines in humans remains a challenge. To address this issue, we developed a Lymphoid Organ-Chip (LO chip) model based on a microfluidic chip seeded with human PBMC at high density within a 3D collagen matrix. ... ...

    Abstract Predicting the immunogenicity of candidate vaccines in humans remains a challenge. To address this issue, we developed a Lymphoid Organ-Chip (LO chip) model based on a microfluidic chip seeded with human PBMC at high density within a 3D collagen matrix. Perfusion of the SARS-CoV-2 Spike protein mimicked a vaccine boost by inducing a massive amplification of Spike-specific memory B cells, plasmablast differentiation, and Spike-specific antibody secretion. Features of lymphoid tissue, including the formation of activated CD4+ T cell/B cell clusters and the emigration of matured plasmablasts, were recapitulated in the LO chip. Importantly, myeloid cells were competent at capturing and expressing mRNA vectored by lipid nanoparticles, enabling the assessment of responses to mRNA vaccines. Comparison of on-chip responses to Wuhan monovalent and Wuhan/Omicron bivalent mRNA vaccine boosts showed equivalent induction of Omicron neutralizing antibodies, pointing at immune imprinting as reported in vivo. The LO chip thus represents a versatile platform suited to the preclinical evaluation of vaccine boosting strategies.
    Keywords covid19
    Language English
    Publishing date 2024-02-02
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2024.02.02.578553
    Database COVID19

    Kategorien

  2. Article ; Online: Global loss of cellular m

    Vaid, Roshan / Mendez, Akram / Thombare, Ketan / Burgos-Panadero, Rebeca / Robinot, Rémy / Fonseca, Barbara F / Gandasi, Nikhil R / Ringlander, Johan / Hassan Baig, Mohammad / Dong, Jae-June / Cho, Jae Yong / Reinius, Björn / Chakrabarti, Lisa A / Nystrom, Kristina / Mondal, Tanmoy

    Genome research

    2023  Volume 33, Issue 3, Page(s) 299–313

    Abstract: Insights into host-virus interactions during SARS-CoV-2 infection are needed to understand COVID-19 pathogenesis and may help to guide the design of novel antiviral therapeutics. ...

    Abstract Insights into host-virus interactions during SARS-CoV-2 infection are needed to understand COVID-19 pathogenesis and may help to guide the design of novel antiviral therapeutics.
    MeSH term(s) Humans ; SARS-CoV-2/genetics ; COVID-19/genetics ; Methylation ; RNA ; RNA, Viral/genetics ; Methyltransferases/genetics
    Chemical Substances RNA (63231-63-0) ; RNA, Viral ; METTL3 protein, human (EC 2.1.1.62) ; Methyltransferases (EC 2.1.1.-)
    Language English
    Publishing date 2023-03-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1284872-4
    ISSN 1549-5469 ; 1088-9051 ; 1054-9803
    ISSN (online) 1549-5469
    ISSN 1088-9051 ; 1054-9803
    DOI 10.1101/gr.276407.121
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Divergent adaptive immune responses define two types of long COVID.

    Kervevan, Jérôme / Staropoli, Isabelle / Slama, Dorsaf / Jeger-Madiot, Raphaël / Donnadieu, Françoise / Planas, Delphine / Pietri, Marie-Pierre / Loghmari-Bouchneb, Wiem / Alaba Tanah, Motolete / Robinot, Rémy / Boufassa, Faroudy / White, Michael / Salmon-Ceron, Dominique / Chakrabarti, Lisa A

    Frontiers in immunology

    2023  Volume 14, Page(s) 1221961

    Abstract: Background: The role of adaptive immune responses in long COVID remains poorly understood, with contrasting hypotheses suggesting either an insufficient antiviral response or an excessive immune response associated with inflammatory damage. To address ... ...

    Abstract Background: The role of adaptive immune responses in long COVID remains poorly understood, with contrasting hypotheses suggesting either an insufficient antiviral response or an excessive immune response associated with inflammatory damage. To address this issue, we set to characterize humoral and CD4+ T cell responses in long COVID patients prior to SARS-CoV-2 vaccination.
    Methods: Long COVID patients who were seropositive (LC+, n=28) or seronegative (LC-, n=23) by spike ELISA assay were recruited based on (i) an initial SARS-CoV-2 infection documented by PCR or the conjunction of three major signs of COVID-19 and (ii) the persistence or resurgence of at least 3 symptoms for over 3 months. They were compared to COVID patients with resolved symptoms (RE, n=29) and uninfected control individuals (HD, n=29).
    Results: The spectrum of persistent symptoms proved similar in both long COVID groups, with a trend for a higher number of symptoms in the seronegative group (median=6
    Conclusions: These findings provide evidence for two major types of antiviral immune responses in long COVID. Seropositive patients showed coordinated cellular and humoral responses at least as high as those of recovered patients. In contrast, ELISA-seronegative long COVID patients showed overall low antiviral responses, with detectable specific CD4+ T cells and/or antibodies in close to half of patients (52.2%). These divergent findings in patients sharing a comparable spectrum of persistent symptoms raise the possibility of multiple etiologies in long COVID.
    MeSH term(s) Humans ; Post-Acute COVID-19 Syndrome ; COVID-19 ; COVID-19 Vaccines ; SARS-CoV-2 ; Antibodies, Viral ; Antiviral Agents ; Immunoglobulin G
    Chemical Substances COVID-19 Vaccines ; Antibodies, Viral ; Antiviral Agents ; Immunoglobulin G
    Language English
    Publishing date 2023-07-20
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1221961
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.

    Gellenoncourt, Stacy / Saunders, Nell / Robinot, Rémy / Auguste, Lucas / Rajah, Maaran Michael / Kervevan, Jérôme / Jeger-Madiot, Raphaël / Staropoli, Isabelle / Planchais, Cyril / Mouquet, Hugo / Buchrieser, Julian / Schwartz, Olivier / Chakrabarti, Lisa A

    Journal of virology

    2022  Volume 96, Issue 19, Page(s) e0130122

    Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remained genetically stable during the first 3 months of the pandemic, before acquiring a D614G spike mutation that rapidly spread worldwide and then generating successive waves of viral ... ...

    Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remained genetically stable during the first 3 months of the pandemic, before acquiring a D614G spike mutation that rapidly spread worldwide and then generating successive waves of viral variants with increasingly high transmissibility. We set out to evaluate possible epistatic interactions between the early-occurring D614G mutation and the more recently emerged cleavage site mutations present in spike of the Alpha, Delta, and Omicron variants of concern. The P681H/R mutations at the S1/S2 cleavage site increased spike processing and fusogenicity but limited its incorporation into pseudoviruses. In addition, the higher cleavage rate led to higher shedding of the spike S1 subunit, resulting in a lower infectivity of the P681H/R-carrying pseudoviruses compared to those expressing the Wuhan wild-type spike. The D614G mutation increased spike expression at the cell surface and limited S1 shedding from pseudovirions. As a consequence, the D614G mutation preferentially increased the infectivity of P681H/R-carrying pseudoviruses. This enhancement was more marked in cells where the endosomal route predominated, suggesting that more stable spikes could better withstand the endosomal environment. Taken together, these findings suggest that the D614G mutation stabilized S1/S2 association and enabled the selection of mutations that increased S1/S2 cleavage, leading to the emergence of SARS-CoV-2 variants expressing highly fusogenic spikes.
    MeSH term(s) COVID-19/virology ; Humans ; Mutation ; SARS-CoV-2/genetics ; SARS-CoV-2/pathogenicity ; Spike Glycoprotein, Coronavirus/genetics
    Chemical Substances Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2
    Language English
    Publishing date 2022-09-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/jvi.01301-22
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.

    Dufloo, Jérémy / Grzelak, Ludivine / Staropoli, Isabelle / Madec, Yoann / Tondeur, Laura / Anna, François / Pelleau, Stéphane / Wiedemann, Aurélie / Planchais, Cyril / Buchrieser, Julian / Robinot, Rémy / Ungeheuer, Marie-Noelle / Mouquet, Hugo / Charneau, Pierre / White, Michael / Lévy, Yves / Hoen, Bruno / Fontanet, Arnaud / Schwartz, Olivier /
    Bruel, Timothée

    Cell reports. Medicine

    2021  Volume 2, Issue 5, Page(s) 100275

    Abstract: Many SARS-CoV-2-infected individuals remain asymptomatic. Little is known about the extent and quality of their antiviral humoral response. Here, we analyze antibody functions in 52 asymptomatic infected individuals, 119 mildly symptomatic, and 21 ... ...

    Abstract Many SARS-CoV-2-infected individuals remain asymptomatic. Little is known about the extent and quality of their antiviral humoral response. Here, we analyze antibody functions in 52 asymptomatic infected individuals, 119 mildly symptomatic, and 21 hospitalized patients with COVID-19. We measure anti-spike immunoglobulin G (IgG), IgA, and IgM levels with the S-Flow assay and map IgG-targeted epitopes with a Luminex assay. We also evaluate neutralization, complement deposition, and antibody-dependent cellular cytotoxicity (ADCC) using replication-competent SARS-CoV-2 or reporter cell systems. We show that COVID-19 sera mediate complement deposition and kill infected cells by ADCC. Sera from asymptomatic individuals neutralize the virus, activate ADCC, and trigger complement deposition. Antibody levels and functions are lower in asymptomatic individuals than they are in symptomatic cases. Antibody functions are correlated, regardless of disease severity. Longitudinal samplings show that antibody functions follow similar kinetics of induction and contraction. Overall, asymptomatic SARS-CoV-2 infection elicits polyfunctional antibodies neutralizing the virus and targeting infected cells.
    MeSH term(s) Adolescent ; Adult ; Antibodies, Viral/blood ; Antibodies, Viral/immunology ; Antibody-Dependent Cell Cytotoxicity ; Antigen-Antibody Reactions ; Asymptomatic Diseases ; COVID-19/pathology ; COVID-19/virology ; Complement System Proteins/metabolism ; Epitopes/immunology ; Female ; Humans ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Killer Cells, Natural/immunology ; Male ; Middle Aged ; Neutralization Tests ; SARS-CoV-2/isolation & purification ; SARS-CoV-2/metabolism ; Severity of Illness Index ; Spike Glycoprotein, Coronavirus/immunology ; Young Adult
    Chemical Substances Antibodies, Viral ; Epitopes ; Immunoglobulin G ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; Complement System Proteins (9007-36-7)
    Language English
    Publishing date 2021-04-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2666-3791
    ISSN (online) 2666-3791
    DOI 10.1016/j.xcrm.2021.100275
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.

    Claireaux, Mathieu / Robinot, Rémy / Kervevan, Jérôme / Patgaonkar, Mandar / Staropoli, Isabelle / Brelot, Anne / Nouël, Alexandre / Gellenoncourt, Stacy / Tang, Xian / Héry, Mélanie / Volant, Stevenn / Perthame, Emeline / Avettand-Fenoël, Véronique / Buchrieser, Julian / Cokelaer, Thomas / Bouchier, Christiane / Ma, Laurence / Boufassa, Faroudy / Hendou, Samia /
    Libri, Valentina / Hasan, Milena / Zucman, David / de Truchis, Pierre / Schwartz, Olivier / Lambotte, Olivier / Chakrabarti, Lisa A

    Nature communications

    2022  Volume 13, Issue 1, Page(s) 521

    Abstract: HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely ... ...

    Abstract HIV elite controllers maintain a population of CD4 + T cells endowed with high avidity for Gag antigens and potent effector functions. How these HIV-specific cells avoid infection and depletion upon encounter with the virus remains incompletely understood. Ex vivo characterization of single Gag-specific CD4 + T cells reveals an advanced Th1 differentiation pattern in controllers, except for the CCR5 marker, which is downregulated compared to specific cells of treated patients. Accordingly, controller specific CD4 + T cells show decreased susceptibility to CCR5-dependent HIV entry. Two controllers carried biallelic mutations impairing CCR5 surface expression, indicating that in rare cases CCR5 downregulation can have a direct genetic cause. Increased expression of β-chemokine ligands upon high-avidity antigen/TCR interactions contributes to autocrine CCR5 downregulation in controllers without CCR5 mutations. These findings suggest that genetic and functional regulation of the primary HIV coreceptor CCR5 play a key role in promoting natural HIV control.
    MeSH term(s) CD4-Positive T-Lymphocytes/immunology ; Chemokines ; Down-Regulation ; Elite Controllers ; Gene Expression Regulation ; Gene Products, gag/metabolism ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/immunology ; Histocompatibility Antigens Class II ; Humans ; Mutation ; Receptors, CCR5/genetics ; Receptors, CCR5/metabolism ; Receptors, CXCR3 ; Virus Internalization
    Chemical Substances CCR5 protein, human ; CXCR3 protein, human ; Chemokines ; Gene Products, gag ; Histocompatibility Antigens Class II ; Receptors, CCR5 ; Receptors, CXCR3
    Language English
    Publishing date 2022-01-26
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-022-28130-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The spike-stabilizing D614G mutation interacts with S1/S2 cleavage site mutations to promote the infectious potential of SARS-CoV-2 variants

    Gellenoncourt, Stacy / Saunders, Nell / Robinot, Remy / Auguste, Lucas / Rajah, Maaran Michael / Kervevan, Jerome / Jeger-Madiot, Raphael / Staropoli, Isabelle / Planchais, Cyril / Mouquet, Hugo / Buchrieser, Julian / Schwartz, Olivier / Chakrabarti, Lisa A.

    bioRxiv

    Abstract: SARS-CoV-2 remained genetically stable during the first three months of the pandemic, before acquiring a D614G spike mutation that rapidly spread worldwide, and then generating successive waves of viral variants with increasingly high transmissibility. ... ...

    Abstract SARS-CoV-2 remained genetically stable during the first three months of the pandemic, before acquiring a D614G spike mutation that rapidly spread worldwide, and then generating successive waves of viral variants with increasingly high transmissibility. We set out to evaluate possible epistatic interactions between the early occurring D614G mutation and the more recently emerged cleavage site mutations present in spike of the Alpha, Delta, and Omicron variants of concern. The P681H/R mutations at the S1/S2 cleavage site increased spike processing and fusogenicity but limited its incorporation into pseudoviruses. In addition, the higher cleavage rate led to higher shedding of the spike S1 subunit, resulting in a lower infectivity of the P681H/R-carrying pseudoviruses compared to those expressing the Wuhan wild-type spike. The D614G mutation increased spike expression at the cell surface and limited S1 shedding from pseudovirions. As a consequence, the D614G mutation preferentially increased the infectivity of P681H/R-carrying pseudoviruses. This enhancement was more marked in cells where the endosomal route predominated, suggesting that more stable spikes could better withstand the endosomal environment. Taken together, these findings suggest that the D614G mutation stabilized S1/S2 association and enabled the selection of mutations that increased S1/S2 cleavage, leading to the emergence of SARS-CoV-2 variants expressing highly fusogenic spikes.
    Keywords covid19
    Language English
    Publishing date 2022-05-20
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2022.05.20.492832
    Database COVID19

    Kategorien

  8. Article ; Online: Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies

    Jérémy Dufloo / Ludivine Grzelak / Isabelle Staropoli / Yoann Madec / Laura Tondeur / François Anna / Stéphane Pelleau / Aurélie Wiedemann / Cyril Planchais / Julian Buchrieser / Rémy Robinot / Marie-Noelle Ungeheuer / Hugo Mouquet / Pierre Charneau / Michael White / Yves Lévy / Bruno Hoen / Arnaud Fontanet / Olivier Schwartz /
    Timothée Bruel

    Cell Reports Medicine, Vol 2, Iss 5, Pp 100275- (2021)

    2021  

    Abstract: Summary: Many SARS-CoV-2-infected individuals remain asymptomatic. Little is known about the extent and quality of their antiviral humoral response. Here, we analyze antibody functions in 52 asymptomatic infected individuals, 119 mildly symptomatic, and ... ...

    Abstract Summary: Many SARS-CoV-2-infected individuals remain asymptomatic. Little is known about the extent and quality of their antiviral humoral response. Here, we analyze antibody functions in 52 asymptomatic infected individuals, 119 mildly symptomatic, and 21 hospitalized patients with COVID-19. We measure anti-spike immunoglobulin G (IgG), IgA, and IgM levels with the S-Flow assay and map IgG-targeted epitopes with a Luminex assay. We also evaluate neutralization, complement deposition, and antibody-dependent cellular cytotoxicity (ADCC) using replication-competent SARS-CoV-2 or reporter cell systems. We show that COVID-19 sera mediate complement deposition and kill infected cells by ADCC. Sera from asymptomatic individuals neutralize the virus, activate ADCC, and trigger complement deposition. Antibody levels and functions are lower in asymptomatic individuals than they are in symptomatic cases. Antibody functions are correlated, regardless of disease severity. Longitudinal samplings show that antibody functions follow similar kinetics of induction and contraction. Overall, asymptomatic SARS-CoV-2 infection elicits polyfunctional antibodies neutralizing the virus and targeting infected cells.
    Keywords SARS-CoV-2 ; ADCC ; complement ; asymptomatic ; antibody ; Medicine (General) ; R5-920
    Subject code 570
    Language English
    Publishing date 2021-05-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.

    Rajah, Maaran Michael / Hubert, Mathieu / Bishop, Elodie / Saunders, Nell / Robinot, Remy / Grzelak, Ludivine / Planas, Delphine / Dufloo, Jérémy / Gellenoncourt, Stacy / Bongers, Alice / Zivaljic, Marija / Planchais, Cyril / Guivel-Benhassine, Florence / Porrot, Françoise / Mouquet, Hugo / Chakrabarti, Lisa A / Buchrieser, Julian / Schwartz, Olivier

    The EMBO journal

    2021  Volume 40, Issue 24, Page(s) e108944

    Abstract: Severe COVID-19 is characterized by lung abnormalities, including the presence of syncytial pneumocytes. Syncytia form when SARS-CoV-2 spike protein expressed on the surface of infected cells interacts with the ACE2 receptor on neighboring cells. The ... ...

    Abstract Severe COVID-19 is characterized by lung abnormalities, including the presence of syncytial pneumocytes. Syncytia form when SARS-CoV-2 spike protein expressed on the surface of infected cells interacts with the ACE2 receptor on neighboring cells. The syncytia forming potential of spike variant proteins remain poorly characterized. Here, we first assessed Alpha (B.1.1.7) and Beta (B.1.351) spread and fusion in cell cultures, compared with the ancestral D614G strain. Alpha and Beta replicated similarly to D614G strain in Vero, Caco-2, Calu-3, and primary airway cells. However, Alpha and Beta formed larger and more numerous syncytia. Variant spike proteins displayed higher ACE2 affinity compared with D614G. Alpha, Beta, and D614G fusion was similarly inhibited by interferon-induced transmembrane proteins (IFITMs). Individual mutations present in Alpha and Beta spikes modified fusogenicity, binding to ACE2 or recognition by monoclonal antibodies. We further show that Delta spike also triggers faster fusion relative to D614G. Thus, SARS-CoV-2 emerging variants display enhanced syncytia formation.
    MeSH term(s) Angiotensin-Converting Enzyme 2/metabolism ; Animals ; Antibodies, Monoclonal/pharmacology ; Caco-2 Cells ; Cell Line ; Chlorocebus aethiops ; Giant Cells/drug effects ; Giant Cells/metabolism ; Giant Cells/virology ; HEK293 Cells ; Humans ; Mutation ; SARS-CoV-2/drug effects ; SARS-CoV-2/genetics ; SARS-CoV-2/physiology ; Spike Glycoprotein, Coronavirus/genetics ; Vero Cells ; Virus Replication/drug effects
    Chemical Substances Antibodies, Monoclonal ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Language English
    Publishing date 2021-10-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 586044-1
    ISSN 1460-2075 ; 0261-4189
    ISSN (online) 1460-2075
    ISSN 0261-4189
    DOI 10.15252/embj.2021108944
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

    Mathieu Claireaux / Rémy Robinot / Jérôme Kervevan / Mandar Patgaonkar / Isabelle Staropoli / Anne Brelot / Alexandre Nouël / Stacy Gellenoncourt / Xian Tang / Mélanie Héry / Stevenn Volant / Emeline Perthame / Véronique Avettand-Fenoël / Julian Buchrieser / Thomas Cokelaer / Christiane Bouchier / Laurence Ma / Faroudy Boufassa / Samia Hendou /
    Valentina Libri / Milena Hasan / David Zucman / Pierre de Truchis / Olivier Schwartz / Olivier Lambotte / Lisa A. Chakrabarti

    Nature Communications, Vol 13, Iss 1, Pp 1-

    2022  Volume 19

    Abstract: Here, Claireaux et al. show that people who naturally control HIV infection express lower levels of the viral co-receptor CCR5 in specific CD4+ T cells, and that this results from mutations or receptor internalization by CD4+ T cell-produced chemokines. ...

    Abstract Here, Claireaux et al. show that people who naturally control HIV infection express lower levels of the viral co-receptor CCR5 in specific CD4+ T cells, and that this results from mutations or receptor internalization by CD4+ T cell-produced chemokines.
    Keywords Science ; Q
    Language English
    Publishing date 2022-01-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top